For research use only. Not for therapeutic Use.
Taurodeoxycholic acid sodium salt hydrate (CAS 207737-97-1) has been <span style="font-size:12px;"><span style="color:#000000;"><span style="font-family: Arial, Helvetica, sans-serif; orphans: 2; widows: 2;">used in a study to assess the effect of submicellar concentrations of bile salts on the lipid bilayer membrane. </span></span><span style="color:#000000;"><span style="font-family: Arial, Helvetica, sans-serif; orphans: 2; widows: 2;">It has also been used in a study to investigate polymorphic behavior in protein-surfactant mixtures. </span></span></span>
Catalog Number | M003422 |
CAS Number | 207737-97-1 |
Synonyms | TAURODEOXYCHOLIC ACID SODIUM SIGMAULTRA;2-([3α,12α-dihydroxy-24-oxo-5β-cholan-24-yl]amino)ethanesulfonic acid;Taurodeoxycholic acid hydrate sodium salt, 2-([3α,12α-Dihydroxy-24-oxo-5β-cholan-24-yl]amino)ethanesulfonic acid;N-(Deoxycholyl)taurin |
Molecular Formula | C26H46NNaO7S |
Purity | ≥95% |
Target | Metabolic Enzyme/Protease |
Storage | Store at -20°C |
IUPAC Name | sodium;2-[[(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate;hydrate |
InChI | InChI=1S/C26H45NO6S.Na.H2O/c1-16(4-9-24(30)27-12-13-34(31,32)33)20-7-8-21-19-6-5-17-14-18(28)10-11-25(17,2)22(19)15-23(29)26(20,21)3;;/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33);;1H2/q;+1;/p-1/t16-,17-,18-,19+,20-,21+,22+,23+,25+,26-;;/m1../s1 |
InChIKey | OLPIZAYYAVQETM-GGPRKOIFSA-M |
SMILES | CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C.O.[Na+] |
Reference | <p> |